Table 2.

Changes in outcome measures between baseline and the 3-month follow-up

Outcome measures	BIS initiation at week 2 (n = 45)	BIS initiation at week 12 (n = 45)	p value
de Morton Mobility Index  Baseline  3-month follow-up  Change in scores	39.0 ± 8.5 61.0 ± 17.9 22.0 ± 14.1	37.8 ± 9.8 62.7 ± 19.0 25.0 ± 15.7	0.522 0.327 0.345
Barthel Index  Baseline  3-month follow-up  Change in scores	57.6 ± 15.1 86.4 ± 13.9 28.8 ± 15.1	59.9 ± 16.8 86.6 ± 14.9 26.7 ± 13.1	0.491 0.668 0.459
EuroQol visual analog scale  Baseline  3-month follow-up  Change in scores	61.0 ± 15.3 75.5 ± 15.9 14.5 ± 16.0	63.1 ± 15.9 78.8 ± 13.9 15.7 ± 16.5	0.527 0.406 0.732
Visual analog scale  Baseline  3-month follow-up  Change in scores	2.7 ± 2.3 1.1 ± 1.9 −1.8 ± 2.6	2.7 ± 2.5 1.1 ± 1.3 −1.6 ± 2.3	0.930 0.977 0.931
Outcome measures	BIS initiation at week 2 (n = 44)	BIS initiation at week 12 (n = 42)	p value
Two-minute walking test (m)  Baseline  3-month follow-up  Change in scores	17.4 ± 18.2 40.5 ± 20.9 23.1 ± 23.0	15.9 ± 8.7 38.8 ± 25.3 22.9 ± 19.8	0.621 0.885 0.971
Timed get-up-and-go test (s)  Baseline  3-month follow-up  Change in scores	71.0 ± 40.3 28.3 ± 16.8 −42.7 ± 33.4	66.1 ± 46.1 32.5 ± 22.1 −33.5 ± 42.9	0.600 0.166 0.272

Data presented as mean ± standard deviation; p value <0.05 indicates statistical significance

BIS bisphosphonate